Mo1111 RNASET2 RISK VARIANT AS A NOVEL BLOOD BASED DIAGNOSTIC FOR DEFINING A SEVERE CD PATIENT POPULATION RESPONSIVE TO DIRECTED RNASET2 THERAPEUTICS

Rivkah Gonsky,Eva Biener-Ramanujan,Ignat. Printsev, Frank Kim,Dermot P. B. McGovern, Janine Bilsborough,Stephan R. Targan

GASTROENTEROLOGY（2020）

引用 0|浏览27

暂无评分

摘要

incorporates small effect size CD-associated SNPs, was significantly associated with FC in this cohort.Our results suggest that there is an influence of genetic factors on preclinical inflammation in asymptomatic FDRs of CD probands. Mo1108

查看译文

关键词

NK Cell Recognition

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要